Samsrita Labs Ltd.

View in App
17.40 +0.75 ▲4.5%

26 April 2024, 04:01:00 PM
Volume: 756

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.drhlsl.com
Market Cap 25.77 Cr.
Enterprise Value(EV) 27.94 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.48 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 67.02 Trailing Twelve Months Ending 2023-03
Book Value / Share 8.45 Trailing Twelve Months Ending 2023-03
Price to Book Value 2.06 Calculated using Price: 17.40
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.48 Cr. 14,808,706 Shares
FaceValue 10
About Samsrita Labs Ltd.
Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices.

Samsrita Labs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Samsrita Labs Ltd. Performance

View details >>
1 Day
+4.50%
1 Week
+4.44%
1 Month
+25.81%
3 Month
+2.05%
6 Month
+3.57%
1 Year
-7.94%
2 Year
-36.15%
5 Year
-39.79%
10 Year

Samsrita Labs Ltd. Fundamental Ratios

View details >>
7 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -16.62 -11.85 -21.62 -16.88 -6.71 12.29 -5.48
Return on Capital Employed (%) -4.07 -6.81 -12.27 -10.1 -4.53 10.2 -4.61
Return on Assets (%) -6.9 -5.06 -9.63 -7.4 -3.47 8.89 -4.32

Samsrita Labs Ltd. Balance Sheet

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 8 11 12 12 11 13 13
Non Curr. Liab. 0 0 0 0 0 0 0
Curr. Liab. 7 7 10 12 5 4 3
Minority Int. 4 4 4 4
Equity & Liab. 19 23 26 28 17 17 16
Non Curr. Assets 16 18 20 21 10 10 10
Curr. Assets 3 4 6 7 7 7 6
Misc. Exp. not W/O
Total Assets 19 23 26 28 17 17 16

Samsrita Labs Ltd. Profit and Loss

View details >>
Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2021-09 Rs. Cr. TTM 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 1 1 2 1 0 0 0
Other Income 0 0 0 0 0 0 2 0
Total Income 1 1 2 2 0 0 2 0
Total Expenditure -2 -2 -4 -4 -1 0 0 -1
PBIDT -1 -1 -2 -2 -1 0 2 -1
Interest 0 0
Depreciation 0 0 0 0 0 0 0
Taxation -1 0 0 0 0
Exceptional Items
PAT -1 -1 -2 -2 -1 0 2 -1
Minority Interest 0 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit -1 -1 -2 -2 -1 0 1 -1
Adjusted EPS -1 -1 -2 -1 -1 0 1 0

Samsrita Labs Ltd. Cash Flow

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 -3 -3 -1 0 0 1
Cash Fr. Inv. -1 -1 -2 -1 0
Cash Fr. Finan. 1 5 4 2 1 0 -1
Net Change 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0

Samsrita Labs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 52.87 52.87 52.87 52.87 52.87 52.87 52.87 52.87 52.87
Public 47.13 47.13 47.13 47.13 47.13 47.13 47.13 47.13 47.13
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.11
No. of Shareholders (in Lacs)

Samsrita Labs Ltd. Announcements

View details >>
Tue, 23 Apr 2024
Reg. 40(9)&(10) - PCS Certificate
Reg. 40(9)&(10)- PCS Certificate
Tue, 23 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Samsrita Labs Ltd
2 CIN NO. L85110TG1996PLC099198
3 Report filed for FY 2023-2024
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 0
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)0
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Vaani Nitesh Makhija previous name Deepa Rajdenra Dudani
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- KNV Narendra Kumar
Designation : -Wholetime Director and CFO

Date: 23/04/2024
Tue, 23 Apr 2024
Reg 7(3) Compliance Certificate
Reg. 7(3) Compliance Certificate

Samsrita Labs Ltd. Technical Scans

View details >>
Fri, 26 Apr 2024
High Delivery Percentage High Delivery Percentage
High Increase in 1 Month High Increase in 1 Month
20 SMA Crossing 50 SMA From Below 20 SMA Crossing 50 SMA From Below
William %R Crossed -20 From Below William %R Crossed -20 From Below
ROC Trending Up ROC Trending Up

Samsrita Labs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,794.25 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,315.63 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,380.92 947.40 -0.4%
Mankind Pharma Ltd. 94,869.36 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,057.05 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.69 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.95 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.93 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.95 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.39 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Samsrita Labs Ltd. FAQ's

What is Samsrita Labs share price?
Can I buy Samsrita Labs shares now?
What is the Market Cap of Samsrita Labs?
What are the key metrics to analyse Samsrita Labs?
What is the 52 Week High and Low of Samsrita Labs?
What is the trend of Samsrita Labs share price?